These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 30384587
1. DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone ("Flakka"). Kolesnikova TO, Khatsko SL, Demin KA, Shevyrin VA, Kalueff AV. ACS Chem Neurosci; 2019 Jan 16; 10(1):168-174. PubMed ID: 30384587 [Abstract] [Full Text] [Related]
2. The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects. Nóbrega L, Dinis-Oliveira RJ. Drug Metab Rev; 2018 May 16; 50(2):125-139. PubMed ID: 29540067 [Abstract] [Full Text] [Related]
3. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH. Neuropharmacology; 2014 Dec 16; 87():206-13. PubMed ID: 24594476 [Abstract] [Full Text] [Related]
4. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP). Glennon RA, Young R. Brain Res Bull; 2016 Sep 16; 126(Pt 1):111-126. PubMed ID: 27142261 [Abstract] [Full Text] [Related]
8. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'. Wood MR, Lalancette RA, Bernal I. Acta Crystallogr C Struct Chem; 2015 Jan 16; 71(Pt 1):32-8. PubMed ID: 25567572 [Abstract] [Full Text] [Related]
9. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants. Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp JW, Rawls SM, Olive MF. ACS Chem Neurosci; 2018 Oct 17; 9(10):2379-2394. PubMed ID: 29714473 [Abstract] [Full Text] [Related]
10. Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats. Gatch MB, Forster MJ. J Psychopharmacol; 2020 Jul 17; 34(7):778-785. PubMed ID: 32536334 [Abstract] [Full Text] [Related]
11. Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats. Xu P, Lai M, Fu D, Liu H, Wang Y, Shen H, Zhou W. Pharmacol Biochem Behav; 2021 Apr 17; 203():173128. PubMed ID: 33515585 [Abstract] [Full Text] [Related]
12. Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted α-PVP ("flakka") Derivatives. Nadal-Gratacós N, Lleixà E, Gibert-Serramià M, Estrada-Tejedor R, Berzosa X, Batllori X, Pubill D, Camarasa J, Escubedo E, López-Arnau R. Int J Mol Sci; 2022 Feb 17; 23(4):. PubMed ID: 35216339 [Abstract] [Full Text] [Related]
13. When fish take a bath: Psychopharmacological characterization of the effects of a synthetic cathinone bath salt 'flakka' on adult zebrafish. Kolesnikova TO, Khatsko SL, Eltsov OS, Shevyrin VA, Kalueff AV. Neurotoxicol Teratol; 2019 Feb 17; 73():15-21. PubMed ID: 30796953 [Abstract] [Full Text] [Related]
14. Synthetic cathinones: "a khat and mouse game". Katz DP, Bhattacharya D, Bhattacharya S, Deruiter J, Clark CR, Suppiramaniam V, Dhanasekaran M. Toxicol Lett; 2014 Sep 02; 229(2):349-56. PubMed ID: 24973490 [Abstract] [Full Text] [Related]
15. Current "legal highs". Johnson LA, Johnson RL, Portier RB. J Emerg Med; 2013 Jun 02; 44(6):1108-15. PubMed ID: 23528960 [Abstract] [Full Text] [Related]
16. Structural and functional perspectives on interactions between synthetic cathinones and monoamine transporters. Nguyen VT, Harris AC, Eltit JM. Adv Pharmacol; 2024 Jun 02; 99():83-124. PubMed ID: 38467490 [Abstract] [Full Text] [Related]
17. The dangerous new synthetic drug α-PVP as the hydrated chloride salt α-pyrrolidinopentiophenone hydrochloride 0.786-hydrate. Wood MR, Bernal I, Lalancette RA. Acta Crystallogr C Struct Chem; 2016 Jan 02; 72(Pt 1):48-51. PubMed ID: 26742826 [Abstract] [Full Text] [Related]
18. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Liechti M. Swiss Med Wkly; 2015 Jan 02; 145():w14043. PubMed ID: 25588018 [Abstract] [Full Text] [Related]
19. Designer psychostimulants: pharmacology and differences. Iversen L, White M, Treble R. Neuropharmacology; 2014 Dec 02; 87():59-65. PubMed ID: 24456744 [Abstract] [Full Text] [Related]
20. Single chemical entity legal highs: assessing the risk for long term harm. McNabb CB, Russell BR, Caprioli D, Nutt DJ, Gibbons S, Dalley JW. Curr Drug Abuse Rev; 2012 Dec 02; 5(4):304-19. PubMed ID: 23244343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]